相关实验视频

Updated: Mar 16, 2026

In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol

In Vitro Differentiation of Human CD4⁺FOXP3⁺ Induced Regulatory T Cells (iTregs) from Naïve CD4⁺ T Cells Using a TGF-β-containing Protocol

Published on: December 30, 2016

长非编码RNAFOXP1-DT调节了在Graves病中的调节性T细胞

Qian Xu¹, Chuanbin Lu¹, Juan Xu²

¹Department of Endocrinology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, 212002, China.

Scientific reports

|March 15, 2026

概括

低调的FOXP1-DT,一个长非编码RNA,通过损害调节性T细胞 (Tregs) 与Graves病 (GD) 有关. 较低的FOXP1-DT水平与降低的Treg功能相关,可以作为GD的生物标志物.

科学领域:

免疫学免疫学免疫学
分子生物学分子生物学
遗传学遗传学是一个

背景情况:

调节性T细胞 (Tregs) 对于免疫恒温至关重要.
特雷格功能障碍与格雷夫氏病 (GD) 病原发生有关.
在GD中Treg失调的分子机制尚未完全理解.

研究的目的:

调查长非编码RNAFOXP1-DT在GD患者Tregs中的作用.
探索FOXP1-DT,FOXP1表达和GD中的Treg水平之间的关系.

主要方法:

招募了15名GD患者和15名健康对照.
在外周血液单核细胞中量化FOXP1-DT和FOXP1的表达.
与临床参数和Treg细胞频率的相关性分析.
在FOXP1-DT的沉默实验中.
接收器运行特征 (ROC) 曲线分析.

主要成果:

在GD患者中,FOXP1-DT表达显著下降.
减少的FOXP1-DT与甲状腺刺激激素受体抗体水平相反相关.
在GD患者中,FOXP1表达和Treg细胞比例降低,与FOXP1-DT.正相关.
沉默FOXP1-DT减少了FOXP1的表达和Treg比例.
FOXP1-DT证明了作为GD生物标志物的潜力.

结论:

降低调节的FOXP1-DT可能通过破坏FOXP1-介导的Treg平衡来促进GD的发病.
作为潜在的治疗标和格雷夫斯病的诊断生物标志物,FOXP1-DT需要进一步调查.

关键词:

这就是FOXP1P.这就是FOXP1-DT.格雷夫斯的疾病.这是Tregs.在 lncRNAs 中.

更多相关视频

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation

Published on: August 13, 2013

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

Published on: January 22, 2020

相关概念视频

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Master Transcription Regulators

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...